Global Cell Cryopreserving Agent Market Research Report 2021

Cell culture are prone to genetic drift, which are susceptible to microbial contamination. The microbial contamination can lead to experiment failure in laboratories. Beside the cell line are very valuable resource and replacing the cell line will be too costly and time consuming during the experimentation. The best method to store cell line with minimum cost is freezing. The freezing method will enable the long term storage of cell which can be utilized when required in the laboratories. When the small surplus are available for sub culturing, it should be frozen as seed stock therefore duplicates can be obtain when require during experimentation. Cryopreserving is the most widely used method for the preservation of cell culture. In cryopreserving method the cell lines are stored in liquid nitrogen to avoid the microbial contamination. The presence of cryopreserving agents such as dimethylsulfoxide (DMSO) allows slower cooler rate and reduce the rate of ice crystal formation.

The global Cell Cryopreserving Agent market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Cell Cryopreserving Agent volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cell Cryopreserving Agent market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Cell Cryopreserving Agent Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
DMSO (10%)
10% Glycerol
Without DMSO
Others

Segment by Application
Hospitals
Research Institutes
Laboratories
Pharmaceuticals
Biotechnology Companies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Merck
Thermo Fisher Scientific
Nippon Genetics
Miltenyi Biotec
BioLifeSolutions
PromoCell
KOHJIN Life Sciences Co.,Ltd
Abcam
ROKEPIE®BV
Biological Industries
Nacalai Tesque Inc.

Frequently Asked Questions